Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

C3_LIVER_INTRAHEPATIC_BILE_DUCTS_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C22 Hospital discharge: ICD-9 — 155 Hospital discharge: ICD-8 — 155 Cause of death: ICD-10 — C22 Cause of death: ICD-9 — 155 Cause of death: ICD-8 — 155 Cancer registry: Topography ICD-O-3 — C22 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	2304
4. Check minimum number of events None	2304
5. Include endpoints None	2304
6. Filter based on genotype QC (FinnGen only)	2034

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_LIVER_INTRAHEPATIC_BILE_DUCTS_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C22
HD_ICD_9	155
HD_ICD_8	155
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C22
COD_ICD_9	155
COD_ICD_8	155
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C22
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2034	576	1458
Unadjusted period prevalence (%)	0.54	0.20	0.67
Median age at first event (years)	72.05	71.20	72.39

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2117: Matched controls
21169

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

29.3

316.0

214

JN4AD

NOMESCO Finland

Body CT examination

11.0

307.7

578

699

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

20.5

307.7

269

149

A03FA01

ATC

metoclopramide; systemic, rectal

12.5

307.7

878

1132

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

157.6

307.7

670

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

150.3

307.7

641

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

24.6

307.7

247

113

JN4CD

NOMESCO Finland

Very extensive body CT

31.2

307.7

301

112

N02AA05

ATC

oxycodone; systemic

8.2

307.7

997

2078

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

307.7

309

A04AA01

ATC

ondansetron; systemic, rectal

18.2

307.7

296

187

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

32.4

307.7

229

Z51.5

ICD-10 Finland

Palliative care

25.6

307.7

863

554

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

307.7

1160

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

29.8

307.7

338

134

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

307.7

677

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

10.5

307.7

630

821

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

6985.7

307.7

539

R18

ICD-10 Finland

Ascites

22.7

307.7

255

127

H02AB02

ATC

dexamethasone; systemic

45.9

307.7

391

104

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

307.7

601

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

939

A04AA02

ATC

granisetron; systemic, transdermal

671.3

301.2

291

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

18.7

299.9

246

148

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

24.3

298.9

217

JN4BD

NOMESCO Finland

Extensive body CT

9.4

291.0

382

483

WX302

NOMESCO Finland

Thoracal epidural anesthesy

16.0

280.7

250

176

WF002

NOMESCO Finland

Radical radiotherapy

105.4

267.8

138

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2668.5

261.9

248

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

12.2

260.8

275

256

K83.1

ICD-10 Finland

Obstruction of bile duct

29.6

248.9

167

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

+∞

247.9

233

198

Kela drug reimbursment

Sorafenib

+∞

245.7

231

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

242.5

228

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

5.4

234.3

580

1394

8160/3-C22.1

ICD-O-3

Cholangiocarcinoma of intrahepatic bile duct

+∞

229.4

216

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

18.9

222.0

179

103

L01BC06

ATC

capecitabine; oral

+∞

211.0

199

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

34.8

206.1

131

JN3AD

NOMESCO Finland

Abdominal CT examination

5.0

205.1

535

1332

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

17.8

195.8

162

WZC00

NOMESCO Finland

Treatment plan or consultation

3.8

191.1

898

3429

UJK02

NOMESCO Finland

ERCP

9.9

177.8

214

238

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

6.4

177.5

323

577

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

170.1

161

K83.0

ICD-10 Finland

Cholangitis

14.1

168.8

158

120

C61

ICD-10 Finland

Malignant neoplasm of prostate

358.6

167.7

167

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

441.0

166.0

164

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

67.1

164.1

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

24.2

163.0

117

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

9.0

154.0

198

239

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

71.9

153.0

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

1500.5

144.5

139

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

31.7

144.1

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

37.1

142.9

XX3DW

NOMESCO Finland

Time consuming IT work

6.4

134.7

237

406

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

25.6

132.5

L01XE05

ATC

[U] sorafenib

+∞

131.6

125

323

Kela drug reimbursment

Sorafenib

+∞

130.6

124

127

Kela drug reimbursment

Transplant complication

17.1

130.2

109

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

12.0

129.7

134

119

WF049

NOMESCO Finland

Radiotherapy of metastasis

667.5

128.9

126

C03DA01

ATC

spironolactone; oral

3.4

127.5

579

2084

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

+∞

127.4

121

WW500

NOMESCO Finland

Blood transfusion

9.8

127.4

152

166

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.0

127.0

909

4262

A05AA02

ATC

ursodeoxycholic acid; oral

16.9

124.9

105

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

122.1

116

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

45.9

120.2

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

48.2

119.8

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

+∞

116.8

111

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

112.5

107

A06AH03

ATC

naloxegol; oral

22.4

108.5

A07AA11

ATC

rifaximin; oral

36.4

107.0

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.1

106.5

334

930

Z94.4

ICD-10 Finland

Liver transplant status

130.1

104.1

111

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

5.6

102.6

207

402

WZC30

NOMESCO Finland

Teaching

3.5

101.6

426

1440

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

44.1

100.6

D77

ICPC

Malignant digestive neopl other/NOS

516.7

100.4

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

34.1

98.9

116

Kela drug reimbursment

Prostate cancer

+∞

92.4

L04AD02

ATC

tacrolimus; systemic

17.5

92.2

A06AD11

ATC

lactulose; oral

2.9

91.5

578

2463

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

+∞

91.3

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

916.3

90.5

I81

ICD-10 Finland

Portal vein thrombosis

27.3

89.1

K76.9

ICD-10 Finland

Liver disease, unspecified

11.1

88.5

3019

Kela drug reimbursment

Lenvatinib

+∞

88.1

JJC00

NOMESCO Finland

Allogenic transplantation of liver

190.0

88.0

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

20.3

87.2

L01EX02

ATC

sorafenib; oral

+∞

87.1

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

18.1

86.4

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

872.8

86.2

L01EX08

ATC

lenvatinib; oral

+∞

86.0

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

86.0

1508

Kela drug reimbursment

Lenvatinib

+∞

86.0

N02AX02

ATC

tramadol; systemic, rectal

2.4

85.3

1078

6352

L04AA06

ATC

mycophenolic acid; systemic

9.7

85.1

101

109

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.1

84.4

418

1550

B01AB10

ATC

tinzaparin; parenteral

3.8

84.4

286

835

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

12.5

83.5

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

8.2

80.0

109

140

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

9.1

78.1

111

D97

ICPC

Liver disease NOS

21.3

77.1

8160/3-C24.9

ICD-O-3

Cholangiocarcinoma of billiary tract, NOS

+∞

75.5

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

74.4

A79

ICPC

Malignancy NOS

196.9

73.6

B18.2

ICD-10 Finland

Chronic viral hepatitis C

15.2

73.5

A04AA55

ATC

palonosetron, combinations; systemic

+∞

73.4

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

73.3

590

2798

D13.4

ICD-10 Finland

Benign neoplasm: Liver

26.9

72.7

C03CA01

ATC

furosemide; systemic

2.2

71.4

1058

6515

L03AA02

ATC

filgrastim; parenteral

114.1

71.4

ZX120

NOMESCO Finland

Intravenous

3.7

70.7

249

743

C22.7

ICD-10 Finland

Malignant neoplasm: Other specified carcinomas of liver

+∞

68.1

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

237.6

67.6

J01MA12

ATC

levofloxacin; systemic

2.5

67.4

531

2480

103

Kela drug reimbursment

Diabetes, insulin-treated

2.2

67.0

880

5124

B01AB05

ATC

enoxaparin; parenteral

2.3

64.3

712

3853

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

18.6

63.9

TPH07

NOMESCO Finland

Cathetrisation of artery

2.9

63.8

344

1324

R50.9

ICD-10 Finland

Fever, unspecified

2.7

63.2

414

1763

8000/3-C22.1

ICD-O-3

Neoplasm, malignant of intrahepatic bile duct

+∞

61.8

L03AA13

ATC

pegfilgrastim; parenteral

322.1

61.7

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

6.1

61.6

110

189

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

60.7

1158

7700

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

212.8

60.4

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

19.2

59.7

WX402

NOMESCO Finland

General anaesthesia

2.5

58.4

435

1965

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

+∞

57.6

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

57.6

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.1

57.5

796

4666

A10BA02

ATC

metformin; oral

2.1

56.2

872

5324

A10AE04

ATC

insulin glargine; parenteral

2.7

55.9

348

1438

UJF32

NOMESCO Finland

Coloscopy

2.2

55.9

638

3461

WF004

NOMESCO Finland

Palliative radiotherapy

562.4

55.8

PC2SC

NOMESCO Finland

Liver angiography with X-ray

562.4

55.8

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

55.5

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

72.0

55.4

A10AB05

ATC

insulin aspart; parenteral

3.0

55.3

274

1002

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.1

54.5

707

4024

XX2RW, ,

NOMESCO Finland

14.4

52.9

176

Kela drug reimbursment

Regorafenib

+∞

52.3

PJA12

NOMESCO Finland

Sentinel node biopsy

520.3

51.7

115

Kela drug reimbursment

Breast cancer

+∞

51.2

R4110

NOMESCO Finland

Physiotherapy

2.1

51.1

627

3478

K92.0

ICD-10 Finland

Haematemesis

4.6

50.9

126

289

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

6.1

50.8

150

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

21.5

50.7

JAH00

NOMESCO Finland

Laparotomy

5.4

50.6

103

200

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

17.1

50.6

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.7

50.4

172

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

50.2

C24.00

ICD-10 Finland

Hepatic duct

+∞

50.2

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

499.2

49.6

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

499.2

49.6

N02AA01

ATC

morphine; systemic, rectal

6.5

49.3

131

A02BC02

ATC

pantoprazole; systemic

2.0

49.2

1450

10915

KCD02

NOMESCO Finland

Transurethral resection of bladder

13.0

48.7

R4190

NOMESCO Finland

Nutritional therapy

5.3

48.4

193

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

48.4

515

2694

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

11.9

48.2

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

16.1

47.8

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

167.1

47.0

L02AE02

ATC

leuprorelin; implant, parenteral

61.5

46.5

C24.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of biliary tract

+∞

46.0

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

7.4

45.9

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.9

44.9

139

377

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

446.8

44.4

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

+∞

43.9

T90

ICPC

Diabetes non-insulin dependent

2.0

43.6

695

4198

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

14.7

43.4

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

42.9

C22

ICD-10 Finland

Malignant neoplasm of liver and intrahepatic bile ducts

+∞

42.9

B01AB04

ATC

dalteparin; parenteral

3.6

42.7

145

419

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

80.2

42.0

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

10.4

41.4

JJB30

NOMESCO Finland

Excision of two segments of liver

415.4

41.3

L04AD01

ATC

ciclosporin; systemic

6.9

41.3

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.0

41.2

121

316

369

Kela drug reimbursment

Regorafenib

+∞

40.8

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

40.8

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

208.9

40.0

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

208.9

40.0

C24.09

ICD-10 Finland

Biliary duct or passage NOS

+∞

39.7

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.6

39.6

136

396

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

384.1

38.2

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

135.8

37.8

A10BB12

ATC

glimepiride; oral

2.4

37.8

285

1277

J01MA02

ATC

ciprofloxacin; systemic

1.8

37.1

895

6101

SPAT1262

SPAT

Handing over of treatment supplies

2.0

37.0

468

2584

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

193.4

36.9

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

36.6

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.0

36.5

162

TJA10

NOMESCO Finland

Laparocentesis

99.3

35.8

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

35.5

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

35.5

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

35.3

320

1551

JJB71

NOMESCO Finland

Laparoscopic resection of liver

352.9

35.0

A10BH01

ATC

sitagliptin; oral

2.3

34.6

299

1420

JKA20

NOMESCO Finland

Cholecystectomy

3.8

34.5

106

286

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

34.5

L02BB03

ATC

bicalutamide; oral

+∞

34.5

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

34.5

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

34.5

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

33.4

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

+∞

33.4

A04AD12

ATC

aprepitant; systemic

+∞

33.4

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

332.1

33.0

JJA20

NOMESCO Finland

Open biopsy of liver

49.6

32.6

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

10.4

32.5

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.1

32.5

234

L01EX05

ATC

regorafenib; oral

+∞

32.4

8140/3-C80.9

ICD-O-3

Adenocarcinoma, NOS, of unknown primary site

+∞

32.4

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

321.7

31.9

WF003

NOMESCO Finland

Adjuvant radiotherapy

321.7

31.9

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

321.7

31.9

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

5.0

31.5

139

160

Kela drug reimbursment

exenatide

4.4

31.0

181

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

31.0

469

2736

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

30.3

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

30.3

A10BX07

ATC

[U] liraglutide

5.7

30.3

103

WW200, ,

SPAT

0.4

30.0

226

4501

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.9

29.5

434

2503

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

+∞

29.2

C07AG02

ATC

carvedilol; oral

2.5

29.1

205

887

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

40.7

29.0

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

295.9

28.8

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

295.9

28.8

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

28.7

298

1517

Y77

ICPC

Malignant neoplasm prostate

104.9

28.7

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.6

28.2

173

701

JJA44

NOMESCO Finland

Laparoscopic destruction of lesion of liver

+∞

28.2

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

27.8

370

2061

ZX090

NOMESCO Finland

Other technic of radiotherapy

47.8

27.5

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

27.3

667

4469

K72.1

ICD-10 Finland

Chronic hepatic failure

30.5

27.2

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

54.1

27.2

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

27.2

353

1947

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

27.1

A10AE05

ATC

insulin detemir; parenteral

2.6

27.1

160

636

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

274.4

26.8

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

98.0

26.7

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

141.8

26.7

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

6.3

26.2

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

26.1

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

26.1

UJK12

NOMESCO Finland

Peroral cholangioscopy

31.4

25.9

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

263.7

25.7

HAB40

NOMESCO Finland

Wedge excision of mammary gland

24.4

25.7

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

25.0

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

25.0

JAH01

NOMESCO Finland

Laparoscopy

3.9

24.9

195

K92.1

ICD-10 Finland

Melaena

2.5

24.8

170

725

JJ5AT, ,

NOMESCO Finland

253.0

24.7

A41.8

ICD-10 Finland

Other specified sepsis

3.8

24.5

202

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.4

24.4

274

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

48.9

24.3

XW000

NOMESCO Finland

Bone marrow biopsy

3.6

24.3

236

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.4

24.2

175

3585

WPB10

NOMESCO Finland

Making a convalescent care decision

29.5

24.1

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

24.0

9680/3-C22.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of liver

+∞

24.0

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

23.9

315

1741

K75.0

ICD-10 Finland

Abscess of liver

20.9

23.9

HAC20

NOMESCO Finland

Total mastectomy

87.8

23.7

K70.4

ICD-10 Finland

Alcoholic hepatic failure

8.7

23.7

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.5

23.5

K70.1

ICD-10 Finland

Alcoholic hepatitis

6.9

23.4

ZX050

NOMESCO Finland

Stereotactic radiotherapy

54.6

23.1

L02BG04

ATC

letrozole; oral

25.0

23.1

D70.82

ICD-10 Finland

Drug-induced neutropenia

18.7

23.0

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

+∞

23.0

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

23.0

C24.02

ICD-10 Finland

Common bile duct

+∞

23.0

1552X

ICD-9 Finland

Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUMHEPATIS, NON DEFINITUM PRIM/SEC]

+∞

23.0

8000/3-C24.9

ICD-O-3

Neoplasm, malignant of billiary tract, NOS

+∞

23.0

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.4

22.9

245

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

7.4

22.9

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.6

22.7

120

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

232.4

22.7

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

232.4

22.7

162

Kela drug reimbursment

liraglutide

5.1

22.6

JLC30

NOMESCO Finland

Pancreatoduodenectomy

121.3

22.6

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

21.9

JJA43

NOMESCO Finland

Destruction of lesion of liver

+∞

21.9

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

21.9

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

21.9

340

1980

ZZR00

NOMESCO Finland

Flap of skin

8.2

21.8

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.1

21.6

210

1038

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

7.9

21.3

NK6AN

NOMESCO Finland

Total body bone isotope imaging

23.4

21.3

A10AC01

ATC

insulin (human); parenteral

2.1

21.2

229

1178

TK800

NOMESCO Finland

Hemodialysis

3.6

21.0

195

Z2446

NOMESCO Finland

Social worker

2.5

20.9

132

542

L01XE21

ATC

[U] regorafenib

+∞

20.9

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

20.9

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

20.9

8160/3-C24.0

ICD-O-3

Cholangiocarcinoma of extrahepatic bile duct

+∞

20.9

8140/3-C26.9

ICD-O-3

Adenocarcinoma, NOS, of gastrointestinal tract, NOS

+∞

20.9

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

+∞

20.9

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

20.9

N05CF01

ATC

zopiclone; oral

1.6

20.8

677

4812

ZX070

NOMESCO Finland

Intensity modified radiotherapy

77.6

20.7

Z3231

NOMESCO Finland

Registered nurse

1.7

20.6

523

3495

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

212.0

20.6

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.4

20.2

119

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

20.0

146

640

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

23.6

20.0

WVA20

NOMESCO Finland

Medicine administration

3.6

19.8

193

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

19.8

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

19.8

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

19.8

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

19.8

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

19.8

706

5114

K72.9

ICD-10 Finland

Hepatic failure, unspecified

6.5

19.7

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

8.2

19.6

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

19.2

250

1371

WX002

NOMESCO Finland

Sedation and analgesia

1.7

19.2

387

2427

ZXE00

NOMESCO Finland

One hour or less

1.6

19.1

690

5002

ZX108

NOMESCO Finland

Inhalation

7.6

19.1

Z2221

NOMESCO Finland

Medical doctor

1.7

19.0

476

3163

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

18.8

1550A

ICD-9 Finland

Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary

+∞

18.8

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

18.8

M04AA01

ATC

allopurinol; systemic

1.7

18.7

376

2354

XX4BW, ,

NOMESCO Finland

28.1

18.7

H01CB02

ATC

octreotide; parenteral

70.5

18.7

A10BG03

ATC

pioglitazone; oral

3.0

18.7

294

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

23.9

18.6

SPAT1255

SPAT

Intravenous administration of medicine

2.2

18.6

166

793

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

18.4

108

428

205

Kela drug reimbursment

Chronic hypertension

1.5

18.4

750

5577

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

18.3

293

1716

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

18.3

134

589

JFB30

NOMESCO Finland

Right hemicolectomy

7.5

18.2

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.6

18.2

104

407

C10AA07

ATC

rosuvastatin; oral

0.6

18.1

340

5231

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.2

18.1

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.9

18.0

306

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.7

18.0

357

JN6AD

NOMESCO Finland

CT of torso and neck

7.0

17.8

HA1AA

NOMESCO Finland

X-ray mammography

3.6

17.8

168

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

+∞

17.7

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

17.7

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

17.7

B03XA02

ATC

darbepoetin alfa; parenteral

3.8

17.6

141

C20

ICD-10 Finland

Malignant neoplasm of rectum

181.5

17.5

C07AA05

ATC

propranolol; systemic

1.7

17.5

327

2003

Z3226

NOMESCO Finland

Physiotherapist

1.7

17.3

344

2143

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.7

17.3

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.2

17.2

A10BX04

ATC

[U] exenatide

4.7

17.1

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.5

17.0

105

427

WX892

NOMESCO Finland

Monitored bed care

2.1

16.9

179

912

K29.6

ICD-10 Finland

Other gastritis

4.4

16.9

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

16.9

196

1033

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

3.8

16.9

141

K76.89

ICD-10 Finland

Other specified diseases of liver

22.0

16.9

SPAT1109

SPAT

Analgesia with portable analgesic pump

14.2

16.8

ZXC40

NOMESCO Finland

Use of ultrasound

14.2

16.8

A10BH05

ATC

linagliptin; oral

2.1

16.8

156

757

8140/3-C22.1

ICD-O-3

Adenocarcinoma, NOS, of intrahepatic bile duct

+∞

16.7

C22.3

ICD-10 Finland

Malignant neoplasm: Angiosarcoma of liver

+∞

16.7

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

16.7

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

16.7

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

5.5

16.7

N06DX01

ATC

memantine; oral

0.3

16.4

1701

E66.00

ICD-10 Finland

Metabolic syndrome

2.3

16.3

128

579

RS220, ,

NOMESCO Finland

4.9

16.2

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.5

16.1

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

16.1

200

1078

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.0

16.1

118

C10AA05

ATC

atorvastatin; oral

0.7

16.1

597

7909

ZX112

NOMESCO Finland

Subcutaneous

6.0

16.1

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.9

16.0

123

WPA13

NOMESCO Finland

Palliative consultation

14.6

15.8

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

60.5

15.8

C50.99

ICD-10 Finland

Breast, unspecified

+∞

15.6

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

+∞

15.6

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

15.6

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

15.6

C22.4

ICD-10 Finland

Malignant neoplasm: Other sarcomas of liver

+∞

15.6

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

15.6

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

15.6

8140/3-C22.0

ICD-O-3

Adenocarcinoma, NOS, of liver

+∞

15.6

C82.1

ICD-10 Finland

Follicular lymphoma grade II

161.1

15.5

H02AB06

ATC

prednisolone; systemic

1.5

15.4

917

7287

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

38.3

15.4

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.2

15.4

190

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

15.4

102

429

EB1VA, ,

NOMESCO Finland

0.4

15.3

1965

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

3.7

15.3

132

C10AX09

ATC

ezetimibe; oral

0.5

15.3

146

2756

K76.7

ICD-10 Finland

Hepatorenal syndrome

16.2

15.2

WZC15, ,

NOMESCO Finland

28.8

15.2

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.0

15.1

110

ZXD05

NOMESCO Finland

Urgent procedure

1.5

15.1

579

4211

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

31.9

14.8

L02BA01

ATC

tamoxifen; oral

57.1

14.8

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

14.6

318

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

14.6

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

14.6

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

14.6

JKC30

NOMESCO Finland

Partial excision of bile duct and anastomosis to jejunum

+∞

14.6

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

14.6

L04AA10

ATC

[U] sirolimus

80.7

14.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

14.5

157

807

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

14.4

183

993

A10BJ02

ATC

liraglutide; parenteral

2.9

14.4

235

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

14.4

597

4406

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

15.5

14.4

K70.0

ICD-10 Finland

Alcoholic fatty liver

4.3

14.3

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.3

14.3

112

507

WPA43, ,

SPAT

27.4

14.3

EB4VA, ,

NOMESCO Finland

0.3

14.0

1424

N02AA03

ATC

hydromorphone; systemic, rectal

30.2

13.9

A98

ICPC

Health maint/preventive medicine

0.7

13.8

1509

16633

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

13.8

127

614

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

5.3

13.7

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.3

13.7

102

452

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

75.6

13.6

8140/3-C24.0

ICD-O-3

Adenocarcinoma, NOS, of extrahepatic bile duct

+∞

13.6

L02AE04

ATC

triptorelin; parenteral

+∞

13.6

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

13.6

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

13.6

YJ3VG

NOMESCO Finland

MRI examination of abdomen with high intesity magnet for dose design of radiotherapy

+∞

13.6

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

13.6

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

13.6

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

13.6

C22.2

ICD-10 Finland

Malignant neoplasm: Hepatoblastoma

+∞

13.6

L01XE29

ATC

[U] lenvatinib

+∞

13.6

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

13.6

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

21.3

13.3

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

13.2

223

1323

R10.0

ICD-10 Finland

Acute abdomen

2.7

13.0

260

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

28.5

13.0

PC1BC

NOMESCO Finland

Extensive angiography of aorta and abdominal arteries

9.7

12.7

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.5

12.7

329

R11

ICD-10 Finland

Nausea and vomiting

1.9

12.7

154

824

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

12.6

288

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

70.3

12.6

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

70.3

12.6

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

12.6

619

4702

JJ1AT

NOMESCO Finland

Puncture of lesion of liver with ultrasound guidance

32.2

12.6

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

12.5

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

12.5

JJB53

NOMESCO Finland

Excision of segments IV,V, VI, VII and VIII of liver

+∞

12.5

C24.01

ICD-10 Finland

Cystic duct

+∞

12.5

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

12.5

8010/3-C22.0

ICD-O-3

Carcinoma, NOS, of liver

+∞

12.5

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

12.5

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

+∞

12.5

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

12.5

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

12.5

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.9

12.5

154

828

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

130.8

12.4

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

130.8

12.4

Z51.0

ICD-10 Finland

Radiotherapy session

130.8

12.4

K74.3

ICD-10 Finland

Primary biliary cirrhosis

9.0

12.2

J94.8

ICD-10 Finland

Other specified pleural conditions

3.4

12.1

129

D75

ICPC

Malignant neoplasm colon/rectum

26.8

12.0

J01DB01

ATC

cefalexin; oral

1.4

12.0

1511

13454

P20

ICPC

Memory disturbance

0.6

12.0

163

2779

WPA11

NOMESCO Finland

Developing a plan for palliative care

21.4

12.0

ZZA00

NOMESCO Finland

Split skin graft

2.8

11.9

209

R94.5

ICD-10 Finland

Abnormal results of liver function studies

4.4

11.9

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

11.8

196

3164

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

14.7

11.8

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.3

11.7

417

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.3

11.7

379

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

11.6

400

5474

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.4

11.6

343

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

65.3

11.6

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

11.5

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

11.5

8246/3-C80.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of unknown primary site

+∞

11.5

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

+∞

11.5

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

11.5

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

11.5

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

11.5

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

11.5

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

11.5

YJ1CD

NOMESCO Finland

Very extensive CT examination of abdomen for dose design of radiotherapy

+∞

11.5

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

11.5

X76

ICPC

Malignant neoplasm breast female

120.6

11.4

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

120.6

11.4

E34.0

ICD-10 Finland

Carcinoid syndrome

120.6

11.4

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

120.6

11.4

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.1

11.4

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.5

11.4

297

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.9

11.3

358

Kela drug reimbursment

liraglutide

5.2

11.3

P15

ICPC

Chronic alcohol abuse

2.6

11.2

251

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.5

11.2

A10BD07

ATC

metformin and sitagliptin; systemic

2.1

11.1

109

540

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

4.2

11.1

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.6

11.1

247

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

14.0

11.0

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

11.0

549

4167

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.2

10.9

411

E0000UV, ,

ATC

1.4

10.9

707

5612

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.4

10.9

1327

D70.89

ICD-10 Finland

Neutropenic splenomegaly

5.4

10.9

N05AX08

ATC

risperidone; systemic

0.4

10.9

1450

P01AB01

ATC

metronidazole; oral, rectal

1.4

10.9

634

4942

L04AX01

ATC

azathioprine; systemic

2.3

10.9

341

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

8.9

10.8

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

17.9

10.7

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

10.7

116

597

XF612

NOMESCO Finland

Measurement of central venous pressure

21.6

10.7

C10AC01

ATC

colestyramine; oral

2.8

10.6

194

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

10.6

136

742

G93.4

ICD-10 Finland

Encephalopathy, unspecified

8.5

10.5

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.0

10.5

120

629

L04AA18

ATC

[U] everolimus

110.6

10.4

H01CB03

ATC

lanreotide; parenteral

110.6

10.4

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

110.6

10.4

8140/3-C24.9

ICD-O-3

Adenocarcinoma, NOS, of billiary tract, NOS

+∞

10.4

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

10.4

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

10.4

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

+∞

10.4

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

10.4

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

10.4

ZX020

NOMESCO Finland

HDR radiotherapy within tissue

+∞

10.4

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

10.4

L01CB01

ATC

etoposide; systemic

+∞

10.4

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

+∞

10.4

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

10.4

L01AX03

ATC

temozolomide; systemic

+∞

10.4

J01FF01

ATC

clindamycin; systemic

1.4

10.4

480

3585

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

7.7

10.4

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

10.3

204

3160

A10BB01

ATC

glibenclamide; oral

1.8

10.3

157

904

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

9.6

10.3

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

23.5

10.2

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.2

10.2

396

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.3

10.2

338

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.9

10.2

123

658

WX882

NOMESCO Finland

High dependency care

2.5

10.1

252

XQ902

NOMESCO Finland

Other photography

3.9

10.1

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

0.7

9.9

298

4214

K51.5

ICD-10 Finland

Left sided colitis

2.7

9.9

190

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

9.9

219

A10AD05

ATC

insulin aspart; parenteral

2.5

9.9

261

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.9

9.9

B01AF01

ATC

rivaroxaban; oral

0.5

9.8

108

1964

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.0

9.8

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.7

9.7

187

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

55.2

9.6

D76

ICPC

Malignant neoplasm pancreas

55.2

9.6

K83.3

ICD-10 Finland

Fistula of bile duct

55.2

9.6

PC1CC

NOMESCO Finland

Very extensive angiography of aorta and abdominal arteries

11.4

9.6

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.5

9.6

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.6

9.5

155

2524

TQW99

NOMESCO Finland

Other minor procedure on skin

2.3

9.4

330

L04AH02

ATC

everolimus; oral

100.5

9.4

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

100.5

9.4

I85

ICD-10 Finland

Oesophageal varices

100.5

9.4

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

9.4

135

763

A06AH05

ATC

naldemedine; oral

30.2

9.4

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

9.4

491

D69.5

ICD-10 Finland

Secondary thrombocytopenia

17.6

9.4

WPA44

NOMESCO Finland

Nursing home for palliative care

17.6

9.4

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

9.4

181

2827

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

9.4

YX9AW, ,

NOMESCO Finland

+∞

9.4

C90.0

ICD-10 Finland

Multiple myeloma

+∞

9.4

TQW20

NOMESCO Finland

Tatoe

+∞

9.4

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

9.4

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

9.4

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

9.4

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

9.4

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

9.4

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

9.4

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

9.4

1990X

ICD-9 Finland

Malignant neoplasm without specification of site, Disseminated

+∞

9.4

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.2

9.3

351

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.4

9.3

N06DA02

ATC

donepezil; oral

0.4

9.3

1243

B02AA02

ATC

tranexamic acid; systemic

1.7

9.1

161

967

SPAT1110

SPAT

Measurement of pain intensity

4.8

9.1

K74.0

ICD-10 Finland

Hepatic fibrosis

11.5

9.1

A07AA09

ATC

vancomycin; oral

3.2

9.1

111

A07AA02

ATC

nystatin; oral

1.9

9.1

105

554

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.8

9.0

154

R4110, ,

SPAT

0.5

9.0

1690

WX004

NOMESCO Finland

Patient-controlled sedation

9.1

9.0

WPA44, ,

SPAT

10.1

9.0

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

36.8

9.0

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

36.8

9.0

OAB43, ,

SPAT

0.5

9.0

1401

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

8.9

128

723

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.5

8.9

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.9

8.9

144

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.4

8.9

JFB00

NOMESCO Finland

Partial resection of small intestine

3.4

8.9

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.1

8.8

380

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

8.7

133

767

C50

ICD-10 Finland

Malignant neoplasm of breast

50.2

8.7

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

0.2

8.7

427

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

8.6

346

2509

N03AX16

ATC

[U] pregabalin

1.4

8.6

380

2806

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

8.5

460

K76.6

ICD-10 Finland

Portal hypertension

27.6

8.5

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

3.7

8.4

ZXC96

NOMESCO Finland

Robot assisted procedure

7.4

8.4

V03AF03

ATC

calcium folinate; systemic

90.4

8.4

A10BG02

ATC

rosiglitazone; oral

2.7

8.4

172

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

8.3

8140/3-C23.9

ICD-O-3

Adenocarcinoma, NOS, of gallbladder

+∞

8.3

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

8.3

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

8.3

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

8.3

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

+∞

8.3

JK5ZT

NOMESCO Finland

Implantation of bile duct prosthesis with combined percutaneous transhepatic and endoscopic retrograde technic

+∞

8.3

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

8.3

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

8.3

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

8.3

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

8.3

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

8.3

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

+∞

8.3

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

8.3

L01BC04

ATC

carmofur; oral

+∞

8.3

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

8.3

L02BB04

ATC

enzalutamide; oral

+∞

8.3

8000/3-C23.9

ICD-O-3

Neoplasm, malignant of gallbladder

+∞

8.3

L02BX02

ATC

degarelix; parenteral

+∞

8.3

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

8.3

JJA40

NOMESCO Finland

Excision of lesion of liver

+∞

8.3

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

8.3

1551A

ICD-9 Finland

Malignant neoplasm of liver and intrahepatic bile ducts, Intrahepatic bile ducts

+∞

8.3

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

8.3

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

8.3

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

8.3

834

7000

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

8.3

454

3480

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

8.2

125

719

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

3.2

8.2

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

8.2

412

3110

A28

ICPC

Limited function/disability NOS

1.4

8.2

427

3244

SPAT1088

SPAT

Blood transfusion

7.6

8.2

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.1

8.1

378

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.0

8.1

419

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.6

8.1

169

A10BD03

ATC

metformin and rosiglitazone; systemic

2.5

8.1

199

E83.50

ICD-10 Finland

Hypercalcemia

3.4

8.1

JCA20

NOMESCO Finland

Ligature of oesophageal varices

33.5

8.1

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

33.5

8.1

V03AE01

ATC

polystyrene sulfonate; oral

2.9

8.1

130

I86.4

ICD-10 Finland

Gastric varices

17.2

8.1

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

17.2

8.1

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

17.2

8.1

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

8.9

8.0

OAA67, ,

SPAT

0.4

8.0

899

Z94.0

ICD-10 Finland

Kidney transplant status

4.1

8.0

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.1

8.0

TDA90, ,

SPAT

0.4

8.0

968

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

8.0

107

593

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.9

8.0

106

586

KGH10

NOMESCO Finland

Operation for phimosis

2.1

7.9

328

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

4.3

7.9

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.0

7.9

389

ZY010

NOMESCO Finland

Hospital outpatient

2.2

7.9

283

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

7.8

7.9

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

7.8

185

1198

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

10.8

7.8

UJD02

NOMESCO Finland

Gastroscopy

1.9

7.8

101

554

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

7.8

324

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.0

7.8

111

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

9.4

7.8

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.8

7.7

104

577

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

45.1

7.7

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.4

7.7

204

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

7.7

309

2241

S77

ICPC

Malignant neoplasm of skin

18.4

7.6

SPAT1269

SPAT

Other puncture and/or drainage

6.7

7.6

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

25.1

7.6

WPA41

NOMESCO Finland

Psychosocial conversational support in palliative care

25.1

7.6

JG1CG

NOMESCO Finland

Extensive MRI of rectum

25.1

7.6

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.4

7.5

206

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

7.5

144

886

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.7

7.5

210

3027

WX419

NOMESCO Finland

Other general anesthesy

3.9

7.4

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.7

7.4

229

3241

SPAT1122

SPAT

Ascites puncture

80.4

7.4

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

80.4

7.4

T73

ICPC

Neoplasm endocrine other/unspecified

80.4

7.4

UJF92

NOMESCO Finland

Capsular endoscopy

2.7

7.4

148

N06DA03

ATC

rivastigmine; oral, transdermal

0.4

7.4

852

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

7.7

7.4

A10BH02

ATC

vildagliptin; oral

2.4

7.4

208

ZX121

NOMESCO Finland

Central venous catheter

13.4

7.4

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

4.0

7.3

AXX01, ,

SPAT

0.3

7.3

598

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

7.3

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

7.3

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

+∞

7.3

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

7.3

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

7.3

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

7.3

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

7.3

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

7.3

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

7.3

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

7.3

6603

FHL

Delete a block

+∞

7.3

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

7.3

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

7.3

8010/3-C80.9

ICD-O-3

Carcinoma, NOS, of unknown primary site

+∞

7.3

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

7.3

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

7.3

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

7.3

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

7.3

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

7.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

7.3

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

7.3

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

7.3

1552A

ICD-9 Finland

Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUM HEPATIS, PRIMARIUM ALIUD]

+∞

7.3

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

7.3

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

7.3

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

7.3

N05BA04

ATC

oxazepam; oral

1.4

7.3

453

3535

SPAT1111

SPAT

Planning of analgesia

3.2

7.3

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

7.2

201

1351

L15

ICPC

Knee symptom/complaint

0.7

7.2

233

3271

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

15.8

7.2

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

7.2

120

710

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.7

7.2

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.7

7.2

436

5501

WZC00, ,

SPAT

0.6

7.1

111

1834

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

7.1

484

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.2

7.1

270

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.0

7.0

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.4

6.9

869

L08

ICPC

Shoulder symptom/complaint

0.7

6.9

215

3040

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

7.5

6.9

WPA13, ,

SPAT

13.8

6.9

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

0.6

6.9

1645

A10BJ01

ATC

exenatide; parenteral

3.3

6.8

UKC02

NOMESCO Finland

Cystoscopy

1.4

6.8

321

2391

PJA10

NOMESCO Finland

Exploration of lymph nodes

6.7

6.8

C09BA02

ATC

enalapril and diuretics; systemic

1.5

6.8

189

1271

TPX15

NOMESCO Finland

Removal of vascular injection port

11.0

6.8

WPA43

NOMESCO Finland

A doctor's home visit to perform palliative care

40.2

6.8

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

40.2

6.8

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

40.2

6.8

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

40.2

6.8

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

16.7

6.7

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.4

6.7

747

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.9

6.7

L02AE03

ATC

goserelin; implant

22.6

6.7

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

6.6

394

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.9

6.6

100

T93

ICPC

Lipid disorder

0.4

6.6

892

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

0.3

6.6

622

RD210, ,

NOMESCO Finland

3.0

6.5

OAB42, ,

SPAT

0.6

6.5

1594

G04CB02

ATC

dutasteride; oral

0.6

6.5

1643

E83.1

ICD-10 Finland

Disorders of iron metabolism

5.7

6.4

H02

ICPC

Hearing complaint

0.6

6.4

160

2369

PJD99

NOMESCO Finland

Excision of other lymph nodes

70.1

6.4

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

7.4

6.4

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.2

6.4

222

KC1GB

NOMESCO Finland

Cystography with X-ray

14.3

6.4

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.5

6.4

154

D02AX

ATC

Other emollients and protectives

2.3

6.4

191

HAB99

NOMESCO Finland

Other partial excision of mammary gland

6.6

6.3

D64.8

ICD-10 Finland

Other specified anaemias

2.4

6.3

173

ZXE90

NOMESCO Finland

More than 22 hours

3.5

6.3

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

9.3

6.3

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.7

6.3

114

G04CA52

ATC

tamsulosin and dutasteride; systemic

0.7

6.3

161

2367

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

6.3

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

6.3

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

+∞

6.3

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

6.3

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

+∞

6.3

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

6.3

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

6.3

128

Kela drug reimbursment

Cancers of female genital organs

+∞

6.3

XX7GT

NOMESCO Finland

Selective internal radio therapy (SIRT) with Yttrium

+∞

6.3

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

6.3

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

6.3

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

6.3

8180/3-C22.0

ICD-O-3

Combined hepatocellular carcinoma and cholangiocarcinoma of liver

+∞

6.3

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

6.3

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

6.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

6.3

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

6.3

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

6.3

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

6.3

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

6.3

9120/3-C22.0

ICD-O-3

Hemangiosarcoma of liver

+∞

6.3

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

6.3

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

6.3

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

6.3

8010/3-C22.1

ICD-O-3

Carcinoma, NOS, of intrahepatic bile duct

+∞

6.3

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

6.3

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

6.3

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

6.3

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

6.3

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

6.3

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

6.3

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

6.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

6.3

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.0

6.2

D02AE01

ATC

carbamide; topical

1.7

6.2

104

617

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

26.7

6.2

DAB10

NOMESCO Finland

Partial excision of auricle

26.7

6.2

QX9VV, ,

NOMESCO Finland

26.7

6.2

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

6.2

132

834

XX9XW, ,

NOMESCO Finland

7.0

6.2

ED1AA

NOMESCO Finland

Mandibular X-ray examination

7.0

6.2

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.6

6.2

132

H02AB04

ATC

methylprednisolone; systemic

1.4

6.2

246

1778

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.7

6.2

121

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.6

6.1

1386

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.0

6.1

293

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.5

6.1

145

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.5

6.1

145

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

6.1

508

D01AC02

ATC

miconazole; topical

1.6

6.1

157

1040

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.9

6.0

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

1.9

6.0

407

H02AB09

ATC

hydrocortisone; systemic

2.5

6.0

146

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

844

1712

7.54

307.65

10.6

2.2

23.35

8.13

umol/l

13.97

803

1504

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1200

904

29.34

307.65

4.8

1.4

33.86

2.79

ug/l

2.13

1065

675

(3023183) Ammonium ion [Moles/volume] in Plasma

511

415

15.91

307.65

5.0

2.5

43.28

35.73

umol/l

2.19

480

365

(4035726) Immunohistochemistry procedure

508

417

15.71

307.65

1.6

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

415

414

12.22

307.65

1.5

1.1

556.67

1630.00

titre

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

873

1400

9.91

307.65

5.4

2.0

0.17

0.19

g/l

16.64

822

1264

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

502

199

32.75

307.65

4.1

1.9

987.51

32.58

u/ml

2.75

470

183

(40768441) Liver Pathology biopsy report

478

131.06

307.65

1.7

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

292

203

16.52

307.65

1.3

1.1

1.66

1.55

g/l

2.33

277

179

(3007566) Smooth muscle Ab [Titer] in Serum

421

403

12.79

307.65

1.5

1.1

105.16

104.05

titre

0.01

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

791

331

37.55

307.65

4.5

1.9

1329.43

395.88

u/ml

0.83

717

265

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

613

1302

6.22

288.98

1.7

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

146

78.33

272.75

4.1

2.5

1992.23

5.80

ug/l

1.70

146

(3017143) Hepatitis C virus Ab [Presence] in Serum

573

1211

6.12

270.16

1.7

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

685

1774

5.23

255.46

11.2

6.8

8.70

11.60

mmol/l

16.77

663

1678

(3033658) Prothrombin time (PT) actual/Normal

1004

3946

3.94

208.08

15.2

3.8

74.70

82.07

16.74

984

3852

(3023487) Leukocytes [#/volume] in Peritoneal fluid

139

29.68

207.86

2.1

2.8

6100.58

482.51

e6/l

0.53

101

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1549

8278

4.25

200.10

26.1

3.9

25.49

12.83

umol/l

24.51

1525

7786

(3024561) Albumin [Mass/volume] in Serum or Plasma

1461

7532

4.03

198.32

15.4

4.0

31.44

35.15

g/l

92.85

1420

6949

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

177

131

14.65

192.20

1.5

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

388

814

5.61

179.97

1.8

1.4

1.45

1.15

g/l

2.61

353

748

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1109

5027

3.53

177.85

11.7

2.6

65.77

38.81

u/l

6.24

1078

4705

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

116

30.62

175.61

2.0

2.7

2458.22

54541.41

e6/l

0.56

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1133

5289

3.46

171.60

5.5

2.4

57.58

61.16

u/l

0.80

1097

4855

(3012095) Magnesium [Moles/volume] in Serum or Plasma

743

2690

3.71

167.83

5.7

2.6

0.76

0.82

mmol/l

29.92

718

2475

(3044007) Cell count panel - Peritoneal fluid

113

28.36

166.80

2.0

—

(3033799) Differential panel - Peritoneal fluid

113

27.70

165.44

2.1

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

411

1021

4.75

155.14

2.3

12.97

11.01

g/l

9.83

378

939

(3021879) Hepatitis B virus core Ab [Presence] in Serum

332

730

5.21

144.60

1.4

—

(3032080) INR in Blood by Coagulation assay

1485

8806

3.30

139.35

22.9

20.2

1.29

1.39

inr

13.33

1290

7441

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

549

1815

3.73

139.15

3.9

2.2

262.50

232.97

u/l

2.04

537

1684

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

479

1444

3.99

138.84

5.1

2.3

35.00

39.24

u/l

0.53

423

1180

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

223

354

6.92

136.50

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

117

16.24

135.91

1.6

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

24.16

135.23

4.2

2.2

0.59

mmol/l

0.21

(3023368) Bacteria identified in Blood by Culture

1047

5244

2.97

130.36

6.7

4.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

486

1541

3.80

130.31

2.4

1.7

1.66

1.59

1.21

426

1312

(3044640) Blood type and Crossmatch panel - Blood

993

4848

2.97

129.35

4.3

2.2

—

(3042733) HLA Ab [Presence] in Serum

21.34

124.65

1.4

4.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

172

228

8.12

123.52

8.3

5.8

1103.19

559.20

iu/ml

0.74

(3024471) HLA-A [Type]

25.57

122.62

1.0

—

(3024932) HLA-DR beta [Type]

25.26

120.66

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

29.65

120.14

1.2

1.3

41.65

25.51

g/l

0.34

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

212

369

6.27

118.24

4.8

2.3

2.90

3.49

g/l

4.89

206

350

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

813

3701

2.94

118.21

4.3

2.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

114

13.04

117.04

2.3

2.2

32.14

44.49

iu/ml

0.26

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

113

13.21

116.94

1.2

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

656

2680

3.10

115.50

3.0

2.8

23.24

22.45

0.60

639

2463

(3026692) Albumin [Mass/volume] in Peritoneal fluid

18.97

114.59

1.6

2.0

10.13

13.64

g/l

1.42

(3026250) Tacrolimus [Mass/volume] in Blood

18.32

109.05

43.2

37.3

6.75

7.30

ug/l

1.22

(3004789) Transferrin [Mass/volume] in Serum or Plasma

673

2905

2.93

106.04

3.0

2.7

2.30

2.24

g/l

1.31

636

2651

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

121

129

9.89

102.99

1.3

1.2

157.65

136.09

titre

0.09

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1194

6995

2.62

101.20

4.9

2.5

—

estimate

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

102

12.27

101.07

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

102

12.27

101.07

1.1

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

150

216

7.40

99.95

1.3

1.4

146.68

155.39

au/ml

0.28

(3018677) aPTT in Platelet poor plasma by Coagulation assay

651

2841

2.86

99.60

3.3

1.9

31.64

29.93

7.48

640

2765

(3022948) Iron [Moles/volume] in Serum or Plasma

691

3112

2.81

99.57

3.0

2.7

12.63

12.51

umol/l

0.15

663

2862

(3006922) Hepatitis E virus Ab [Presence] in Serum

105

11.46

99.46

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

260

632

4.55

98.91

2.8

1.5

0.26

0.34

mg/l

1.46

285

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

158

254

6.64

94.97

1.4

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1352

8625

2.57

92.43

18.9

6.1

4.39

4.47

e9/l

0.48

1215

7298

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

155

252

6.56

92.12

1.4

1.3

—

20.29

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

159

266

6.38

91.88

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

146

224

6.93

91.70

1.4

1.2

322.21

279.40

u/ml

0.68

126

(3002256) Pathology report gross observation

354

1157

3.47

88.26

1.5

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

206

455

4.91

87.90

6.8

3.0

1.67

1.78

mg/l

0.90

193

386

(4281824) Cell count and differential, peritoneal fluid

13.01

86.65

1.3

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

121

173

7.36

80.97

3.0

2.7

356.60

245.25

u/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

157

303

5.52

78.00

1.4

1.2

—

(3042936) Bacteria identified in Isolate by Culture

542

2435

2.65

75.60

2.8

2.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

13.53

70.96

33.1

28.3

131.15

133.38

ug/l

0.06

(3003458) Phosphate [Moles/volume] in Serum or Plasma

522

2375

2.59

70.36

8.3

5.6

1.06

1.04

mmol/l

0.94

497

2168

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

16.22

70.26

1.1

—

(3000991) Gas panel - Venous blood

413

1672

2.83

70.14

14.7

8.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

126

7.93

69.13

1.0

280.09

283.68

mg/l

0.13

113

(3016650) Hepatitis A virus Ab [Presence] in Serum

118

195

6.35

68.81

1.2

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

217

610

3.85

67.12

3.7

2.8

0.29

0.35

iu/ml

1.58

104

353

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

19.72

66.88

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

420

1757

2.73

66.71

12.5

7.1

1.76

1.45

mmol/l

3.40

409

1714

(3014007) Fractional oxyhemoglobin in Arterial blood

336

1262

2.98

65.21

14.6

9.1

94.69

93.37

3.96

336

1256

(40768804) Tissue Pathology biopsy report

808

4584

2.23

65.17

2.6

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

118

209

5.92

64.11

1.1

1.0

—

(3018418) pH of Serum or Plasma

863

5064

2.19

63.62

5.9

3.5

7.40

3.19

671

3673

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

8.62

61.97

1.3

1.2

90.25

83.33

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1270

8758

2.12

60.24

12.1

6.3

1.19

1.21

mmol/l

7.78

1121

7519

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1175

7873

2.11

60.13

11.8

6.0

1.19

1.21

mmol/l

6.63

1137

7140

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1368

9745

2.14

59.01

11.8

3.2

221.61

52.21

u/l

65.82

1317

8940

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

321

1243

2.87

58.57

15.0

9.1

0.60

0.64

1.24

321

1236

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

178

483

3.93

57.70

1.9

1.7

—

(3016502) Oxygen saturation in Arterial blood

453

2114

2.45

56.54

12.5

7.0

96.48

94.70

8.78

443

2041

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

323

1286

2.78

55.77

14.8

8.8

1.39

1.33

0.63

323

1276

(3019977) pH of Arterial blood

483

2333

2.39

55.74

12.0

6.9

7.41

7.42

0.12

223

1355

(3002173) Hemoglobin [Mass/volume] in Arterial blood

423

1926

2.49

55.61

13.1

7.5

116.52

122.29

g/l

6.88

415

1892

(3027801) Oxygen [Partial pressure] in Arterial blood

484

2344

2.38

55.50

12.0

6.9

12.51

11.29

kpa

6.95

469

2250

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

483

2344

2.37

55.08

12.0

6.9

4.98

5.05

kpa

0.88

468

2252

(3015377) Calcium [Moles/volume] in Serum or Plasma

877

5414

2.06

54.38

7.0

2.1

2.34

2.35

mmol/l

0.84

839

4737

(3037522) Nuclear Ab [Titer] in Serum

431

2010

2.44

53.60

1.5

1.3

370.98

518.12

titre

1.34

102

467

(3003396) Base excess in Arterial blood by calculation

478

2340

2.35

53.24

12.0

6.9

0.27

1.03

mmol/l

3.96

401

1906

(42870588) Differential panel, method unspecified - Blood

864

5349

2.04

52.73

8.2

5.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

307

1230

2.75

52.19

1.9

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

281

1076

2.86

52.05

13.6

9.6

15.53

15.97

1.70

273

1049

(3013826) Glucose [Moles/volume] in Serum or Plasma

1401

10329

2.05

51.66

12.8

4.9

7.48

6.93

mmol/l

12.60

1369

9843

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

121

273

4.64

49.92

2.0

1.5

132.75

25.24

u/ml

1.95

116

259

(46235355) HIV 1 and 2 tests - Meaningful Use set

357

1574

2.53

49.85

1.6

—

(3036489) Thrombin time

176

530

3.53

48.83

3.7

1.8

22.89

20.70

8.73

171

476

(3021447) Carbon dioxide [Partial pressure] in Venous blood

434

2127

2.31

47.68

5.6

3.5

5.52

5.85

kpa

8.25

429

2060

(3002032) Base excess in Venous blood by calculation

426

2079

2.31

47.23

5.7

3.5

1.03

1.78

mmol/l

3.65

347

1789

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

8.26

46.66

1.6

1.3

—

(3012544) pH of Venous blood

435

2154

2.28

46.53

5.6

3.5

7.38

0.37

285

1259

(3030467) Casts [#/volume] in Urine by Automated count

789

4899

1.97

46.28

4.1

3.2

0.94

0.48

e6/l

2.83

620

3619

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

281

1143

2.68

46.09

16.1

9.0

23.77

24.18

mmol/l

1.40

276

1106

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

599

3389

2.07

45.51

6.4

2.2

2.51

2.45

mmol/l

23.33

565

2965

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

220

791

2.99

45.48

2.2

1.7

2.26

1.95

ug/l

0.29

208

686

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

10.22

45.23

1.8

1.5

2144627.50

1930639.80

iu/ml

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1573

12392

2.05

44.37

29.1

5.7

178.73

78.02

u/l

91.98

1541

11539

(3002030) Lymphocytes/Leukocytes in Blood

1073

7471

1.88

43.73

8.9

5.6

22.84

26.01

15.54

1030

6981

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

510

2761

2.12

43.29

3.6

3.1

1.62

1.90

e6/l

0.48

282

1369

(3007164) IgA [Mass/volume] in Serum or Plasma

494

2642

2.13

43.29

1.7

1.3

3.93

2.79

g/l

14.69

387

1502

(3019069) Monocytes/Leukocytes in Blood

1061

7378

1.88

43.25

9.0

5.7

9.55

9.20

2.88

1007

6804

(3018010) Neutrophils/Leukocytes in Blood

1054

7338

1.87

42.56

8.7

5.6

61.11

58.63

7.83

1011

6928

(3019198) Lymphocytes [#/volume] in Blood

1145

8219

1.86

41.58

8.7

5.5

1.56

1.81

e9/l

11.45

1020

7065

(3006504) Eosinophils/Leukocytes in Blood

1048

7367

1.84

40.24

9.0

5.6

2.60

3.02

7.81

996

6790

(3006315) Basophils [#/volume] in Blood

1126

8107

1.83

39.82

8.7

5.4

0.04

e9/l

3.74

975

6813

(3001604) Monocytes [#/volume] in Blood

1121

8064

1.83

39.72

8.7

5.4

0.64

0.63

e9/l

0.47

972

6771

(3002582) Erythrocytes [#/volume] in Urine

865

5752

1.85

39.57

4.3

3.3

189.19

76.35

e6/l

0.41

700

4422

(3022096) Basophils/Leukocytes in Blood

1045

7379

1.82

39.17

9.1

5.7

0.59

0.65

2.62

990

6800

(40768797) Stomach Pathology biopsy report

428

2242

2.14

39.16

1.4

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

535

3052

2.01

38.82

3.4

3.0

1.01

1.27

e6/l

0.82

305

1673

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

563

3283

1.97

38.29

2.3

1.9

—

(3026782) Osmolality of Urine

573

3373

1.96

37.84

3.6

2.8

539.89

540.17

mosm/kgh2o

0.01

522

2931

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

112

6.05

37.39

1.0

—

(3013115) Eosinophils [#/volume] in Blood

1140

8348

1.79

37.05

9.2

5.5

0.18

0.21

e9/l

10.29

1001

7123

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

254

4.04

34.52

7.8

6.0

12.38

12.34

mg/l

0.02

235

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

735

4833

1.80

33.51

3.0

2.4

3.58

2.80

mg/l

11.13

653

4114

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

421

2317

2.02

33.20

2.2

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

441

2490

1.97

32.24

2.2

1.8

—

(3018095) Leukocytes [#/volume] in Urine

900

6348

1.73

31.63

5.1

3.9

84.15

118.87

e6/l

0.94

710

4545

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

415

6759

0.52

30.83

2.3

1.9

1.54

1.31

mmol/l

5.88

372

5594

(3003694) ABO and Rh group [Type] in Blood

612

3910

1.79

30.12

1.6

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

134

466

3.00

29.17

1.5

224.49

286.72

ug/g

2.61

298

(40758558) Short blood count panel - Blood

696

4678

1.73

28.37

12.9

4.7

—

(3000850) Epithelial cells [#/volume] in Urine

616

4022

1.75

27.73

3.3

2.6

5.96

4.59

e6/l

1.91

577

3646

(3024980) IgG subclass 4 [Mass/volume] in Serum

239

3.75

27.57

2.0

1.6

0.94

0.98

g/l

0.11

189

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

327

1791

1.98

25.61

4.4

3.4

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

268

1368

2.10

25.49

4.0

2.4

66.77

62.39

ml/min/173m2

0.73

117

562

(3031040) Bacteria [#/volume] in Urine by Automated count

1328

10780

1.62

24.35

5.6

4.7

1109.71

2576.94

e6/l

0.88

200

(3024354) Oxygen [Partial pressure] in Venous blood

323

1797

1.94

24.07

4.9

3.0

4.58

4.45

kpa

0.60

318

1733

(3027945) Reticulocytes/Erythrocytes in Blood

394

2369

1.81

22.95

2.9

2.0

2.06

1.74

5.16

356

2080

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

211

1023

2.18

22.83

1.6

1.5

—

(3026008) Bacteria identified in Urine by Culture

713

5121

1.59

21.01

3.5

3.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

247

3.28

20.59

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

253

1370

1.96

20.24

3.2

1.9

410.32

368.15

nmol/l

2.22

235

1244

(3004809) Band form neutrophils/Leukocytes in Blood

196

3.55

20.12

3.9

2.2

2.00

1.42

0.53

163

(40768795) Lymph node Pathology biopsy report

16.23

20.11

1.3

1.1

—

(3045142) Bone marrow Pathology biopsy report

5.42

19.98

1.6

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

5.36

19.21

2.2

1.5

—

(3022145) Colonoscopy Study observation

277

1573

1.88

19.16

1.6

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

146

3.91

19.16

1.1

1.2

55.67

51.41

u/l

0.27

126

(3035637) Corticotropin [Mass/volume] in Plasma

136

3.97

18.54

1.9

1.5

19.72

22.54

ng/l

0.61

136

(3001122) Ferritin [Mass/volume] in Serum or Plasma

905

7013

1.51

18.20

4.0

3.1

205.78

143.84

ug/l

6.53

847

6434

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1362

15512

0.66

17.69

5.8

5.6

4.17

4.35

mmol/l

8.11

1238

14288

(3020630) Protein [Mass/volume] in Serum or Plasma

274

1592

1.83

17.55

2.1

1.7

65.64

66.47

g/l

0.82

248

1420

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

223

1216

1.93

17.40

2.0

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1351

15388

0.66

17.23

5.7

5.5

1.27

1.39

mmol/l

22.51

1215

14057

(21494434) Karyotype in Bone marrow

4.61

17.06

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

174

3.46

16.90

1.4

1.2

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

22.05

16.86

1.1

1.4

1.69

0.61

ml/s/173m2

—

(3021589) Normoblasts [#/volume] in Blood

890

6948

1.48

16.85

23.1

10.5

0.00

e9/l

0.50

713

5610

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

234

1312

1.88

16.76

4.9

3.1

1.21

1.22

mmol/l

1.23

215

1106

(3017181) Myelocytes/Leukocytes in Blood

238

1344

1.87

16.67

4.8

3.7

1.26

0.75

1.84

128

307

(3034274) Bile acid [Moles/volume] in Serum --fasting

4.93

16.64

5.2

1.4

47.55

6.23

umol/l

3.27

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

16.44

16.54

1.4

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

18.05

16.46

1.2

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1408

15863

0.66

16.42

6.3

6.5

2.40

2.50

mmol/l

4.21

1270

14572

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

21.12

15.97

2.0

1.1

—

(3037121) Protein [Mass/volume] in Urine

129

599

2.23

15.48

3.7

2.9

635.94

408.49

mg/l

0.31

228

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

385

2.54

15.47

1.7

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

297

1831

1.72

15.44

3.0

2.0

76.99

66.53

e9/l

3.66

216

1356

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1384

15570

0.68

15.03

6.0

5.7

6.61

6.14

mmol/l

21.91

1253

14065

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

380

2.51

14.90

1.9

1.4

—

(3012501) Base excess in Blood by calculation

363

2.54

14.81

4.5

4.6

2.17

2.79

mmol/l

1.53

238

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

175

929

1.96

14.73

1.8

1.6

1.44

1.54

g/l

0.60

143

802

(40760892) CBC W Ordered Manual Differential panel - Blood

454

3147

1.56

14.73

5.7

4.2

—

(3019060) Gas panel - Arterial blood

221

1275

1.82

14.40

5.3

4.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

369

2.50

14.32

1.5

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

4.17

13.95

1.1

1.2

180.78

88.31

u/l

1.25

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

171

3.21

13.87

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

226

1328

1.79

13.84

7.3

6.1

23.45

24.42

mmol/l

3.03

216

1285

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

120

568

2.18

13.75

1.4

1.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

195

1099

1.85

13.69

4.1

2.7

1.21

1.16

0.35

195

1094

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

193

1087

1.85

13.58

4.1

2.7

0.67

0.61

1.87

193

1082

(1761868) Lipid panel - Serum or Plasma

355

5110

0.63

13.54

4.2

3.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

4.22

13.43

1.1

1.2

48.83

20.43

u/l

1.15

(3002179) Metamyelocytes/Leukocytes in Blood

219

1289

1.78

13.33

4.9

3.6

0.75

0.60

0.62

117

303

(3003181) Sodium [Moles/volume] in Urine

346

2.49

13.26

1.4

51.47

60.08

mmol/l

0.97

276

(3000494) Fungus identified in Specimen by Culture

300

1929

1.65

13.21

1.9

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

5.95

13.06

2.5

2.0

2.43

1.46

0.58

(3026493) Urate [Moles/volume] in Serum or Plasma

623

4716

1.45

12.98

4.0

2.7

374.53

367.77

umol/l

0.72

553

4025

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1314

14788

0.71

12.78

5.1

4.7

1.41

1.28

mmol/l

7.80

1178

13364

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

384

2.38

12.71

1.9

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1375

15345

0.70

12.62

10.0

7.4

43.37

40.74

mmol/mol

14.32

1265

14199

(3021440) Promyelocytes/Leukocytes in Blood

217

1310

1.73

12.07

5.1

3.7

0.15

0.07

0.78

109

275

(3020891) Body temperature

173

987

1.82

11.67

5.2

4.3

36.86

36.90

°c

0.83

173

974

(3021162) Amylase [Enzymatic activity/volume] in Specimen

30.19

11.64

3.6

5.6

1242.65

278.80

u/l

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

3.88

11.38

1.6

1.5

4.68

8.72

u/l

0.74

(3027273) Bicarbonate [Moles/volume] in Venous blood

175

1012

1.79

11.29

4.4

3.0

23.86

25.11

mmol/l

3.91

169

969

(1616796) Gas panel - Central venous blood

412

2.24

11.24

3.7

4.0

—

(3025159) Blasts/Leukocytes in Blood

216

1329

1.70

11.20

5.3

3.9

0.27

0.01

0.67

252

(40768793) Breast Pathology biopsy report

4.61

11.18

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

141

3.17

11.13

2.7

2.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3.97

11.03

2.1

1.5

5.46

113.10

u/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

574

7287

0.71

10.85

3.9

4.0

22.62

24.51

1.69

267

3594

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

250

2.57

10.80

1.9

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

182

2.85

10.72

1.7

1.4

29423.03

64037.77

e6/l

0.47

105

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

10.42

1.0

0.0

—

(3017354) Segmented neutrophils/Leukocytes in Blood

148

3.01

10.28

3.9

2.4

59.22

59.55

0.03

119

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

424

2.15

10.10

1.5

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

294

2024

1.53

9.53

1.9

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

461

3480

1.42

9.29

2.5

1.6

2.78

1.37

mg/l

5.49

395

2751

(3025941) Bacteria identified in Stool by Culture

131

737

1.83

9.27

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

187

2.66

9.12

1.6

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

470

2.02

9.06

4.3

3.6

2.02

1.65

index

0.28

241

(40768806) Pleura Pathology biopsy report

165

2.76

9.05

1.8

1.4

—

(40768800) Prostate Pathology biopsy report

122

3.07

8.98

1.3

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

100

522

1.96

8.90

2.2

168.38

96.21

ug/min

0.56

313

(3014148) Varicella zoster virus Ab [Titer] in Serum

128

3.00

8.90

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

214

2.51

8.82

1.8

1.4

1252.30

1325.22

e6/l

0.05

154

(3007930) Methemoglobin/Hemoglobin.total in Blood

144

853

1.74

8.58

6.3

4.2

0.86

0.85

0.14

135

816

(3000093) Morphology [Interpretation] in Blood Narrative

176

2.65

8.54

1.2

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

339

2.16

8.46

1.6

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

153

929

1.70

8.34

6.2

4.1

1.67

1.61

0.37

146

891

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

8.34

1.0

0.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

171

2629

0.62

8.23

1.3

48.37

38.09

iu/ml

0.22

758

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

22.10

8.01

5.8

3.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1327

14558

0.76

7.95

5.2

4.9

2.44

2.04

mu/l

6.78

1203

13182

(3045788) Cell count panel - Pleural fluid

177

2.58

7.93

2.0

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

201

2.47

7.92

1.6

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

201

2.47

7.92

1.6

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

201

2.47

7.92

1.6

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

201

2.47

7.92

1.6

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

6.11

7.84

1.5

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.89

7.70

2.7

2.5

—

(3012441) Differential panel - Pleural fluid

180

2.53

7.68

1.9

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

790

6636

1.30

7.65

3.3

3.4

1472.87

1663.83

ng/l

0.52

704

5792

(3035933) Granulocytes/Leukocytes in Blood

274

2.22

7.63

3.2

2.9

56.47

59.63

0.91

274

(21494815) CD4 cells/Lymphocytes in Specimen

3.50

7.54

2.2

2.5

33.49

41.83

1.59

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

402

5159

0.73

7.45

2.8

3.0

0.74

ug/l

0.01

269

3525

(3004588) Protein electrophoresis panel - Serum or Plasma

202

1355

1.54

7.35

2.0

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

286

2.17

7.29

1.6

1.3

—

(3035715) Granulocytes [#/volume] in Blood

229

2.30

7.22

3.2

3.1

4.06

4.58

e9/l

0.66

229

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

204

1379

1.53

7.17

4.2

4.0

89.45

95.85

ng/l

0.59

181

1175

(3043409) Potassium [Moles/volume] in Arterial blood

104

593

1.79

7.10

4.3

4.0

3.96

3.95

mmol/l

0.12

104

587

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

164

2453

0.64

6.93

1.2

1.3

16.59

14.89

u/ml

0.09

897

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

121

2.75

6.71

1.3

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

131

811

1.66

6.68

2.0

1.4

7.56

7.53

g/l

0.07

115

713

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

103

597

1.76

6.67

2.1

1.5

0.06

0.02

g/l

0.44

541

(3047181) Lactate [Moles/volume] in Blood

100

575

1.78

6.66

7.3

5.0

1.85

1.37

mmol/l

1.24

515

(3004775) Volume in Urine collected for unspecified duration

157

2.51

6.61

2.0

2.3

888.41

610.69

2.29

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

100

577

1.77

6.58

2.2

1.5

0.00

g/l

-0.00

514

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

130

807

1.65

6.56

2.0

1.4

4.13

3.79

g/l

1.81

115

710

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

481

3841

1.33

6.55

4.5

373.65

473.06

ng/l

0.32

421

3333

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

130

810

1.64

6.47

2.0

1.4

4.36

4.16

g/l

1.77

115

715

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

202

2.31

6.46

1.6

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

992

0.47

6.43

1.8

2.2

3.92

3.54

ratio

1.10

834

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

778

8982

0.79

6.30

4.5

4.3

2.17

2.10

ug/l

0.20

663

8088

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

116

707

1.68

6.29

2.1

1.5

0.47

0.45

g/l

0.03

599

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

149

2.51

6.28

1.0

1.1

—

(3021374) Sirolimus [Mass/volume] in Blood

+∞

6.25

15.2

0.0

8.87

—

ug/l

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

123

763

1.65

6.24

2.1

1.4

2.95

2.97

g/l

0.09

107

667

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

549

1.76

6.24

2.2

1.5

0.00

g/l

-0.00

512

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

115

701

1.68

6.24

1.4

1.2

—

(3037756) Immunofixation for Serum or Plasma

359

1.92

5.96

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

3.54

5.88

1.3

16.73

34.28

u/l

1.59

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

108

660

1.67

5.82

2.1

1.6

39.00

35.18

mg/l

0.67

558

(3034860) Kappa light chains.free [Mass/volume] in Serum

108

661

1.67

5.79

2.1

1.6

55.98

50.84

mg/l

0.42

559

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

115

717

1.64

5.74

2.0

1.4

11.63

10.32

g/l

1.62

617

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

594

1.70

5.72

2.2

1.5

1.52

1.66

ratio

0.34

346

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

3.12

5.62

1.5

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

3.12

5.62

1.5

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

853

7440

1.25

5.57

4.8

4.3

41.24

110.68

ng/l

1.87

732

5844

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

243

2.08

5.53

1.6

1.3

—

(21494814) CD8 cells/Lymphocytes in Specimen

5.39

5.53

1.9

3.1

42.13

24.57

2.12

(3018572) Chloride [Moles/volume] in Blood

383

1.86

5.53

9.0

5.6

105.29

104.95

mmol/l

0.29

353

(3039000) Anion gap in Blood by calculation

383

1.86

5.53

8.9

5.6

12.60

11.65

mmol/l

1.05

353

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

291

1.99

5.52

1.7

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

166

2.31

5.45

3.9

3.4

19.57

11.64

index

1.10

(40761536) Microorganisms panel - Urine sediment

171

1185

1.48

5.37

4.6

3.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

799

6940

1.24

5.36

4.7

4.2

13.51

8.44

mg/mmol

2.09

563

4493

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.93

5.30

1.3

4.5

55.72

61.42

mg/l

0.23

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

247

1837

1.39

5.28

2.9

3.4

216.78

256.44

ng/l

0.93

231

1708

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

114

2.57

5.21

1.7

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

203

2.14

5.15

1.2

191.88

190.90

miu/ml

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

358

1.84

5.06

1.2

1.4

0.76

0.88

nmol/l

0.72

294

(21494755) Public health laboratory ask at order entry panel

713

0.45

5.05

1.1

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

351

1.85

5.05

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

274

1.96

4.99

1.4

1.5

10.50

7.09

u/l

0.93

218

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

148

2.32

4.94

2.0

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

136

2.37

4.91

2.0

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

466

1.72

4.90

4.8

4.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

1609

16940

0.79

4.87

60.6

24.7

123.38

136.01

g/l

146.51

1575

16660

(3010813) Leukocytes [#/volume] in Blood

1609

16940

0.79

4.87

60.1

24.5

7.25

6.89

e9/l

5.45

1562

16380

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1609

16939

0.79

4.86

62.5

25.0

37.27

40.44

101.06

1574

16643

(3026361) Erythrocytes [#/volume] in Blood

1609

16939

0.79

4.86

60.0

24.5

4.15

4.48

e12/l

90.18

1561

16379

(3035941) MCH [Entitic mass]

1609

16938

0.79

4.85

59.8

24.4

30.33

30.55

3.68

1575

16650

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1609

16937

0.79

4.84

59.9

24.5

91.63

91.74

0.36

1577

16646

(3009343) pH of Capillary blood

185

1329

1.43

4.83

4.4

3.8

7.42

7.41

0.22

156

1102

(3007461) Platelets [#/volume] in Blood

1609

16936

0.79

4.83

60.1

24.5

213.56

235.54

e9/l

19.26

1564

16457

(4094501) Cardiovascular stress test using bicycle ergometer

504

0.37

4.80

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

108

2.52

4.71

1.6

12.81

15.55

umol/l

1.14

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

269

0.26

4.71

1.0

1.2

1.26

1.49

g/l

—

269

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1079

11814

0.82

4.67

4.4

3.8

14.81

15.03

pmol/l

2.06

973

10635

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

614

1.61

4.61

2.1

2.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

120

799

1.53

4.59

1.4

1.6

6.07

24.61

iu/ml

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

699

0.48

4.57

1.6

1.9

3.38

3.44

mmol/l

0.11

540

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

617

1.60

4.53

1.5

1.8

47.78

38.09

u/l

2.91

513

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

187

1364

1.41

4.50

4.4

3.8

4.90

5.19

kpa

5.01

175

1294

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

123

2.38

4.49

1.7

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

6.69

4.46

1.0

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

412

1.72

4.41

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

412

1.72

4.41

1.4

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.67

4.32

1.6

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

385

3141

1.28

4.32

1.3

1.42

1.75

u/ml

0.47

823

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

101

2.49

4.30

1.8

1.4

—

(3000012) Reticulocyte production index

282

1.87

4.29

1.9

1.6

1.11

0.88

1.17

188

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1412

15016

0.82

4.29

41.5

16.1

76.01

73.74

ml/min/173m2

3.43

1351

13911

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.71

4.25

1.6

1.3

—

(1002224) Polysomnography panel

544

0.43

4.22

1.0

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1603

16813

0.81

4.14

52.9

22.0

87.05

85.96

umol/l

0.41

1575

16533

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

5.90

4.13

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

154

2.16

4.12

3.2

2.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

104

2.42

4.06

1.8

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

104

2.42

4.06

1.5

1.3

19.12

14.71

u/l

1.31

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

189

2.03

4.04

1.8

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

10.03

4.01

3.6

2.3

145.90

46.76

pmol/l

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

178

2.04

3.90

1.9

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

178

2.04

3.90

1.9

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

119

2.29

3.87

1.9

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

119

2.29

3.87

1.9

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

119

2.29

3.87

1.9

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

180

2.02

3.79

1.9

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

8.77

3.77

2.0

1.0

—

(3009508) Creatinine [Moles/volume] in Urine

776

6902

1.20

3.76

3.9

3.5

6.99

7.59

mmol/l

3.90

655

5796

(3014765) Yersinia sp identified in Stool by Organism specific culture

416

1.66

3.76

1.2

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.74

3.75

2.1

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.74

3.75

2.1

1.3

—

(4062490) Immunoglobulin typing, IgG

141

2.14

3.71

1.6

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.13

3.65

1.2

2.02

7.56

ug/l

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

412

1.65

3.64

1.2

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

709

0.54

3.64

1.2

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

372

0.37

3.63

1.1

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

159

1173

1.38

3.62

4.3

3.7

1.67

1.93

mmol/l

0.29

111

846

(3028192) IgG subclass 2 [Mass/volume] in Serum

143

2.11

3.59

1.6

1.2

3.77

3.08

g/l

0.67

108

(3027135) IgG subclass 1 [Mass/volume] in Serum

143

2.11

3.59

1.6

1.2

7.26

7.30

g/l

0.02

109

(3024139) IgG subclass 3 [Mass/volume] in Serum

143

2.11

3.59

1.6

1.2

0.46

0.43

g/l

0.13

108

(21494890) Protein electrophoresis panel - 24 hour Urine

171

2.00

3.54

1.5

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

439

3715

1.23

3.54

1.9

1.8

1142.40

1160.36

nmol/l

0.14

335

2802

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

245

1938

1.30

3.50

2.5

6.71

7.96

ug/l

0.45

211

1684

(3049717) Cytology report of Urine Cyto stain

649

1.50

3.49

2.7

1.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

208

1.89

3.45

1.8

2.03

1.55

g/24h

0.35

109

(3024522) Salmonella sp identified in Specimen by Organism specific culture

187

1.94

3.44

1.9

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

419

1.62

3.43

1.2

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.77

3.42

2.4

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.77

3.42

2.4

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.77

3.42

2.4

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.77

3.42

2.4

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.35

3.41

1.6

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

211

1645

1.31

3.36

2.9

2.4

196.18

177.01

ug/g

0.32

179

1311

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.72

3.32

1.0

1.1

1656.63

1580.29

miu/ml

0.09

(40768446) Kidney Pathology biopsy report

2.79

3.25

1.1

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

187

0.27

3.25

1.2

1.9

—

(3035880) pH of Pleural fluid

2.39

3.23

1.1

1.4

7.44

0.01

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

185

1.91

3.20

1.9

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.26

3.14

2.1

1.6

—

(3019225) pH of Specimen

211

1662

1.30

3.13

5.4

3.8

7.37

7.36

0.55

191

1112

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

213

0.33

3.06

1.3

1.9

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

7.52

3.05

1.0

1.1

74.67

22.75

u/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

7.52

3.05

2.2

1.4

—

(3008295) Osmolality of Serum or Plasma

182

1.88

3.01

1.1

1.4

278.48

273.35

mosm/kgh2o

0.45

132

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

127

2.06

2.97

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

123

901

1.39

2.97

2.4

2.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

2.55

2.95

2.4

3.5

24.93

29.48

mu/l

0.15

(3008536) Aspergillus sp Ab [Presence] in Serum

4.10

2.88

1.9

1.5

—

(3016750) Collection duration of Urine

102

2.17

2.87

1.9

2.0

500.19

494.23

min

0.12

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.17

2.85

1.1

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1028

0.67

2.79

2.4

2.5

23.50

18.84

au/ml

—

(3012516) Albumin [Mass/volume] in Urine

750

6784

1.16

2.78

3.9

3.5

67.73

49.84

mg/l

1.40

551

4541

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.58

2.78

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

103

741

1.41

2.78

2.0

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

929

0.66

2.74

1.2

1.3

46.43

61.06

au/ml

—

(3000330) Specific gravity of Urine by Test strip

127

952

1.36

2.68

4.4

3.4

1.02

ratio

1.48

115

865

(3015736) pH of Urine

776

7065

1.16

2.60

4.3

3.5

6.27

6.26

0.13

408

3856

(3042631) Mycobacterium sp identified in Specimen

215

1.73

2.56

2.2

2.9

—

(3022313) Gas panel - Capillary blood

124

938

1.34

2.49

5.0

4.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1589

16486

0.85

2.48

34.2

10.8

42.26

25.72

u/l

62.05

1561

15796

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.90

2.41

3.0

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.90

2.41

3.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.90

2.41

3.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.30

2.41

1.4

58.44

103.74

umol/l

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

3.65

2.36

2.4

1.2

94.50

104.32

—

(40765096) Chromosome analysis panel by Banding

4.13

2.36

1.3

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

687

1.39

2.36

1.8

1.7

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.83

2.34

4.8

1.4

1.56

1.87

umol/l

0.39

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

5.56

2.21

1.0

4.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

165

1.77

2.19

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

954

8888

1.13

2.17

4.9

3.8

11.56

2.56

estimate

0.57

235

1786

(4024509) Urine culture

858

0.69

2.15

1.8

1.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

455

4033

1.16

2.14

1.8

43784234.19

38827147.65

pmol/l

0.04

370

3307

(3029937) Albumin [Presence] in Urine by Test strip

564

5079

1.15

2.14

5.2

3.9

0.00

estimate

0.50

187

1559

(3004716) Salmonella sp identified in Stool by Organism specific culture

548

1.40

2.09

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

493

4405

1.16

2.08

4.7

3.4

0.00

0.19

estimate

0.51

176

1338

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.01

2.07

1.0

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

940

8772

1.13

2.05

4.9

3.8

0.00

estimate

0.50

224

1744

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.18

2.04

1.1

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

956

8935

1.13

2.02

4.9

3.9

4.84

0.02

estimate

0.50

210

1631

(3032057) Clostridioides difficile [Presence] in Stool

2.51

2.01

1.7

2.0

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

2.23

2.01

3.1

2.3

29.18

45.75

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

475

4246

1.15

1.99

4.2

3.7

0.00

0.10

—

(3017732) Neutrophils [#/volume] in Blood

228

1918

1.21

1.97

5.2

2.8

6.58

4.70

e9/l

0.87

206

1590

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.99

1.95

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

182

2194

0.81

1.93

4.6

5.4

33.18

32.87

0.12

130

1417

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.76

1.93

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

489

4395

1.15

1.89

3.4

3.0

0.00

0.04

0.78

131

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.19

1.88

1.9

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

356

0.56

1.87

1.3

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

708

1.33

1.86

3.4

3.2

4.13

4.45

pmol/l

2.55

618

(3023103) Potassium [Moles/volume] in Serum or Plasma

1602

16517

0.88

1.85

49.5

21.0

4.03

4.02

mmol/l

0.67

1570

16109

(3023323) Follitropin [Units/volume] in Serum or Plasma

182

1.66

1.85

1.3

1.4

25.54

26.04

iu/l

0.02

147

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.76

1.79

1.3

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

248

1.54

1.76

1.1

202.61

75.57

iu/ml

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1004

0.75

1.73

1.5

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

3.85

1.71

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1602

16494

0.88

1.71

49.4

20.9

137.85

139.78

mmol/l

102.86

1573

16112

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

242

1.54

1.71

2.2

2.3

11.40

18.47

mg/l

—

(3005322) IgE [Units/volume] in Serum or Plasma

910

0.74

1.69

1.2

1.3

295.71

271.38

u/ml

0.10

846

(3002619) Bacteria identified in Specimen by Culture

2.45

1.64

1.1

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.25

1.63

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

720

1.29

1.55

5.4

4.3

24.15

24.76

mmol/l

0.82

649

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.34

1.52

1.8

2.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

0.00

1.52

0.0

1.3

—

15.58

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

627

0.71

1.47

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

2.04

1.43

4.9

1.3

25.08

28.60

umol/l

0.57

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1224

12738

0.91

1.43

52.8

21.6

330.96

332.46

g/l

6.35

1214

12647

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.18

1.40

1.3

16.10

9.40

ug/l

—

(4268621) Lupus anticoagulant assay

150

1.61

1.38

2.4

2.3

—

(3052592) Norovirus Ag [Presence] in Stool

2.36

1.29

1.1

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

210

1.48

1.28

1.2

1.47

3.08

u/ml

0.99

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.94

1.27

1.2

1.1

—

(3034426) Prothrombin time (PT)

2.00

1.23

1.4

29.56

28.62

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

496

1.30

1.21

2.1

2.2

121.43

132.26

g/l

2.59

398

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.11

1.18

1.3

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

265

1.40

1.16

8.5

8.6

9.46

7.49

mmol/l

1.49

223

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.00

1.16

0.0

4.0

—

57.07

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

182

1.49

1.16

1.3

1.4

—

nmol/l

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.97

1.11

1.1

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

703

6630

1.09

1.10

5.1

3.9

0.13

0.09

estimate

0.13

187

1419

(4198724) Urine methamphetamine measurement

2.26

1.10

1.6

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

219

0.59

1.09

1.5

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.38

1.09

1.4

1.8

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

113

1338

0.84

1.08

1.3

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1598

15606

1.10

1.08

41.9

16.5

35.24

26.96

mg/l

18.04

1555

12872

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

210

1.43

1.08

1.2

1.4

1.23

9.09

nmol/l

0.45

202

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

338

0.68

1.07

1.6

1.9

2.28

20.57

iu/l

—

137

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

229

1.40

1.03

1.9

1.5

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1289

12495

1.08

1.00

51.9

19.9

15.12

13.73

123.59

1279

12265

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

211

0.61

0.96

1.3

1.4

—

(3017569) Oxygen content in Arterial blood

133

1.51

0.94

1.7

15.05

16.58

1.57

133

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.62

0.93

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.62

0.93

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

611

0.78

0.93

1.4

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.72

0.92

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

375

1.29

0.91

1.3

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

176

1.43

0.90

1.0

1.3

—

84.75

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

429

1.27

0.90

1.6

0.24

0.23

g/l

0.11

406

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

742

7778

0.93

0.89

2.9

2.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

761

7259

1.08

0.88

3.0

2.4

75.07

77.93

nmol/l

1.70

698

6375

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

167

0.60

0.85

1.5

1.1

—

87.00

—

(4034850) Laboratory test

612

0.80

0.84

15.3

11.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

555

0.79

0.82

1.3

1.7

—

(40761511) CBC panel - Blood by Automated count

1558

15884

0.93

0.82

34.5

15.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.88

0.81

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1.67

0.78

1.3

1.4

0.10

0.22

nmol/l

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

208

1.35

0.77

1.3

1.2

2.35

7.60

u/ml

1.78

103

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

125

0.56

0.77

1.0

1.1

—

(4146454) Self-monitoring of blood glucose

243

1.32

0.77

2.7

2.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

191

1.37

0.77

1.2

1.1

—

(3008898) HLA-B27 [Presence]

348

0.74

0.76

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.70

0.75

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

432

1.23

0.75

1.4

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.84

0.73

1.1

—

(3006270) Folate [Moles/volume] in Blood

159

1.39

0.72

1.2

317.94

334.39

nmol/l

0.13

126

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.58

0.71

1.6

1.3

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.85

0.68

1.2

1.3

—

70.40

—

(3014891) Appearance of Pleural fluid

1.85

0.68

2.4

1.4

—

(3028433) Virus identified in Specimen by Culture

1.67

0.68

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

188

1.33

0.66

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.79

0.66

8.4

9.2

5.08

5.20

mmol/l

—

(3000492) Spirometry study

156

1407

1.12

0.65

1.6

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.54

0.65

1.0

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

515

0.81

0.65

1.5

19698.62

13774.25

e6/l

0.42

374

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

155

1.36

0.63

1.1

1.2

93.14

94.14

0.06

145

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

177

1613

1.11

0.62

1.3

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

138

1.38

0.62

1.8

1.5

8.46

7.82

mmol/l

0.33

138

(40768443) Skin Pathology biopsy report

637

1.17

0.62

1.1

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

104

0.58

0.62

3.3

2.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

875

8469

1.06

0.61

2.3

88.37

92.79

pmol/l

1.94

456

4575

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.60

0.0

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.60

0.0

1.0

—

(3011985) Renin [Units/volume] in Plasma

220

1.28

0.57

1.3

1.4

181.39

74.80

mu/l

0.43

198

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

347

1.21

0.56

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.46

0.56

1.1

1.3

—

0.06

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

0.55

3.2

4.1

13.60

13.31

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

183

0.71

0.55

1.0

1.1

0.36

1.67

u/ml

—

102

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1234

12079

1.05

0.54

5.5

4.4

22.75

12.76

mm/h

43.54

1131

11186

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.50

0.51

1.0

1.2

293.50

241.40

pmol/l

—

(3020650) Glucose [Presence] in Urine

1.50

0.51

1.7

0.00

0.15

estimate

—

(3023419) Bacteria identified in Sputum by Culture

270

0.78

0.51

1.7

2.4

—

(36660697) Celiac disease serology panel - Serum

123

1115

1.11

0.51

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

542

0.85

0.51

1.7

1.9

59.76

43.97

nmol/l

2.96

517

(3023410) Appearance of Cerebral spinal fluid

146

1.30

0.47

1.5

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

188

0.74

0.47

1.4

1.1

—

62.73

—

(3044941) Cell count panel - Synovial fluid

364

0.82

0.46

1.2

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.62

0.45

1.2

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

157

1.28

0.43

1.8

2.0

1.73

1.10

u/field

0.78

(3010726) Horse dander IgE Ab [Units/volume] in Serum

140

0.71

0.43

1.0

1.1

4.15

1.96

u/ml

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

151

0.73

0.42

1.0

1.1

4.12

5.64

u/ml

—

(3019174) dRVVT (LA screen)

0.00

0.41

0.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.5

—

364.73

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.41

0.0

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.40

0.0

1.2

—

330.12

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.00

0.40

0.0

13.3

—

0.21

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.0

—

43.53

—

(3018333) Ribosomal P Ab [Presence] in Serum

114

1.32

0.40

1.1

—

(3033099) Centromere Ab [Titer] in Serum

1.47

0.40

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.47

0.40

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

334

1.17

0.39

1.0

1.1

—

2.50

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.43

0.39

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.39

0.0

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.32

0.37

1.2

39.06

38.86

g/l

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.31

0.37

1.4

1.1

507.00

256.91

iu/ml

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

169

0.77

0.37

1.1

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.43

0.35

3.3

1.9

0.53

1.53

ug/l

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.32

0.35

1.8

1.7

534.83

271.43

mu/l

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

117

1.28

0.35

1.1

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

125

0.72

0.35

1.7

1.5

130.34

163.30

pmol/l

—

125

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

452

1.13

0.34

1.4

1.5

1.54

6.77

iu/ml

0.35

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.33

0.33

1.3

—

(40757373) Influenza virus identified in Isolate

1.28

0.32

1.0

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

130

0.77

0.29

1.2

1.3

91.70

99.32

pmol/l

—

130

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

121

1.24

0.28

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

149

1.21

0.27

1.1

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

116

0.77

0.27

2.6

1.8

69.22

97.23

umol/l

—

116

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.25

0.27

1.0

1.2

—

(4195642) Thrombophilia screening test

187

1.18

0.26

1.3

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

104

1.25

0.26

2.6

1.9

17.67

17.24

nmol/l

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

132

1.21

0.25

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

137

1441

0.95

0.23

2.2

2.3

12.34

15.30

nmol/l

2.91

117

1290

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

534

1.09

0.23

1.6

23.13

22.32

u/ml

0.04

104

(3028707) Methadone [Presence] in Urine by Screen method

1.24

0.23

1.8

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

125

1.20

0.22

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

125

1.20

0.22

1.1

1.2

—

(3003129) Base excess in Capillary blood by calculation

242

0.87

0.22

2.9

2.1

-0.54

0.17

mmol/l

0.21

233

(3028300) Cannabinoids [Presence] in Urine

210

0.86

0.22

1.8

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

163

1.17

0.21

1.0

1.4

—

204.09

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.03

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.0

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

10.02

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

(3027008) Opiates [Presence] in Urine

209

0.86

0.21

1.8

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.16

0.21

1.4

1.6

—

(3024263) Appearance of Synovial fluid

105

0.76

0.21

1.1

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

126

1.19

0.21

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

164

1.16

0.20

1.0

1.1

—

2.32

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

187

0.85

0.20

1.3

1.2

20355.91

152014.08

e6/l

1.89

130

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

374

1.10

0.20

1.9

12.99

12.55

mg/l

0.10

347

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1.23

0.20

2.2

1.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

114

0.79

0.20

1.4

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.18

0.19

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.18

0.19

11.2

7.4

6.43

5.32

kpa

—

(3027944) Amphetamines [Presence] in Urine

207

0.87

0.19

1.8

1.3

—

(3014271) Vancomycin [Susceptibility]

109

1.19

0.18

2.8

3.0

—

(3000764) Benzodiazepines [Presence] in Urine

206

0.87

0.18

1.8

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

558

0.93

0.17

1.3

1.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

157

1.15

0.17

1.0

1.4

—

56.00

—

(3036670) Protein [Mass/volume] in Synovial fluid

0.73

0.17

1.0

1.2

—

38.32

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

515

0.93

0.16

2.7

3.3

0.84

0.82

nmol/l

0.09

414

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

544

1.07

0.16

1.3

1.4

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

162

0.86

0.16

1.3

1.4

16.20

24.86

—

108

(3047189) Immunofixation for 24 hour Urine

1.11

0.16

1.4

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

235

0.89

0.16

1.1

—

4.50

—

(3017704) Immunofixation for Urine

111

1.17

0.15

1.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

149

1.14

0.15

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.79

0.14

1.3

2.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.83

0.13

4.6

4.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

100

1039

0.96

0.13

1.2

1.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

201

1.10

0.11

1.0

1.1

—

20.92

—

(3045424) Erythrocytes [Presence] in Urine

818

1.04

0.11

2.6

2.0

0.00

1.11

estimate

0.50

227

(3016879) Cocaine [Presence] in Urine

198

0.91

0.10

1.8

1.3

—

(3004451) EKG impression Narrative

125

1.12

0.10

1.1

1.3

—

(3019150) Specific gravity of Urine by Refractometry

411

4161

0.98

0.09

5.4

4.0

1.02

kg/l

0.47

295

2733

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

145

1.10

0.09

1.1

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.09

0.09

1.0

1.2

—

13.20

—

(3022689) Creatine [Moles/volume] in Urine

1.07

0.08

1.2

1.5

7.93

8.30

mmol/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.07

0.08

11.2

7.4

6.00

6.02

kpa

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.81

0.08

1.4

151.80

171.59

mmol/24h

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.79

0.08

1.0

1.1

—

21.29

—

(3023420) DNA double strand Ab [Units/volume] in Serum

663

0.96

0.08

1.5

1.7

5.28

6.52

iu/ml

0.24

155

(1001926) Buprenorphine [Presence] in Urine by Screen method

156

1.09

0.08

1.9

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

569

5642

1.01

0.07

1.9

1.7

17.87

19.51

nmol/l

2.23

518

4734

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.86

0.07

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.81

0.07

1.5

1.2

—

(3025130) Human papilloma virus identified in Specimen

0.81

0.07

2.3

1.8

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.80

0.07

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

402

1.05

0.07

4.0

3.6

30.93

30.56

mg/l

0.03

290

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.83

0.07

1.0

1.1

—

(4211845) Urine protein measurement

0.89

0.06

2.4

3.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

354

0.96

0.05

1.3

98.00

765.02

e6/l

1.11

289

(3047007) Chlamydophila sp Ab [Presence] in Serum

159

1.07

0.05

1.1

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

609

6057

1.01

0.05

2.2

2.3

185.29

242.04

u/l

1.57

579

5684

(44806420) Estimation of glomerular filtration rate

140

1.07

0.04

3.5

2.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

150

1.07

0.04

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

131

1.07

0.03

2.9

1.6

—

(3022621) pH of Urine by Test strip

132

1336

0.99

0.03

3.2

2.7

5.90

6.05

1.28

108

937

(3026470) Cobalt [Mass/volume] in Blood

138

0.94

0.02

1.8

2.2

6.18

3.04

ug/l

0.36

128

(3032773) Endomysium IgG Ab [Titer] in Serum

138

0.94

0.02

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

349

0.97

0.02

1.2

1.3

2.00

32.68

e6/l

1.10

271

(3044927) Protein electrophoresis panel - Urine

242

1.03

0.02

1.3

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

197

0.96

0.01

1.3

—

(3045414) Leukocytes [Presence] in Urine

167

1661

1.01

0.01

2.6

2.0

0.00

0.01

estimate

0.50

306

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

227

2278

1.00

0.01

14.5

7.5

—

(3000034) Microalbumin [Mass/volume] in Urine

182

0.99

0.00

4.9

2.9

53.90

32.55

mg/l

0.27

141

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

181

0.99

0.00

1.2

1.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

215

0.98

0.00

1.3

1.5

49.58

63.08

0.62

138

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

305

0.98

0.00

1.3

1.2

—

58.08

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

215

1.02

0.00

3.5

3.9

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

112

0.98

0.00

1.9

81.63

125.43

ng/l

1.34

112

(3016018) Differential panel - Cerebral spinal fluid

156

1.03

0.00

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

716

1.01

0.00

1.2

29.88

108.11

u/ml

4.06

265

(3006653) Thiamine [Moles/volume] in Blood

1.03

0.00

1.1

1.2

109.50

141.42

nmol/l

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

176

1.02

0.00

1.0

1.1

—

(3005570) Glucose [Moles/volume] in Urine

188

1.01

0.00

1.4

2.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.97

0.00

1.2

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.01

0.00

2.0

2.4

9.33

9.79

kpa

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.01

0.00

2.0

2.4

4.70

4.99

kpa

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.89

0.00

2.0

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

-0.00

0.0

2.5

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.9

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.5

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

-0.00

0.0

1.3

—

92.86

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3006462) Nitrate [Presence] in Urine

0.96

-0.00

2.4

3.6

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

4.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

0.02

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

-0.00

0.0

1.0

—

(3006576) Bicarbonate [Moles/volume] in Blood

0.99

-0.00

4.7

7.3

26.84

24.84

mmol/l

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.2

—

1.23

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

166.83

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.2

—

7.98

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.99

-0.00

1.0

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_LIVER_INTRAHEPATIC_BILE_DUCTS_WIDE – Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

GWS hits: 4

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo (C3_LIVER_INTRAHEPATIC_BILE_DUCTS_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints